WO2002102793A3 - Quinazolinediones as antibacterial agents - Google Patents

Quinazolinediones as antibacterial agents Download PDF

Info

Publication number
WO2002102793A3
WO2002102793A3 PCT/IB2002/001768 IB0201768W WO02102793A3 WO 2002102793 A3 WO2002102793 A3 WO 2002102793A3 IB 0201768 W IB0201768 W IB 0201768W WO 02102793 A3 WO02102793 A3 WO 02102793A3
Authority
WO
WIPO (PCT)
Prior art keywords
formula
antibacterial agents
quinazolinediones
compounds
useful
Prior art date
Application number
PCT/IB2002/001768
Other languages
French (fr)
Other versions
WO2002102793A2 (en
Inventor
Edmund Lee Ellsworth
Howard Daniel Hollis Showalter
Sharon Anne Powell
Joseph Peter Sanchez
James Alan Kerschen
Michael Andrew Stier
Tuan Phong Tran
Original Assignee
Warner Lambert Co
Edmund Lee Ellsworth
Howard Daniel Hollis Showalter
Sharon Anne Powell
Joseph Peter Sanchez
James Alan Kerschen
Michael Andrew Stier
Tuan Phong Tran
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co, Edmund Lee Ellsworth, Howard Daniel Hollis Showalter, Sharon Anne Powell, Joseph Peter Sanchez, James Alan Kerschen, Michael Andrew Stier, Tuan Phong Tran filed Critical Warner Lambert Co
Priority to EP02730582A priority Critical patent/EP1401830A2/en
Priority to MXPA03009894A priority patent/MXPA03009894A/en
Priority to CA002446963A priority patent/CA2446963A1/en
Priority to AU2002302894A priority patent/AU2002302894A1/en
Priority to BR0210028-2A priority patent/BR0210028A/en
Priority to JP2003506266A priority patent/JP2005501021A/en
Publication of WO2002102793A2 publication Critical patent/WO2002102793A2/en
Publication of WO2002102793A3 publication Critical patent/WO2002102793A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Abstract

The present invention provides compounds of formula (I): wherein R1-R6 and J and K have any of the values defined in the specification, and pharmaceutically acceptable salt thereof, that are useful as antibacterial agents. Also disclosed are pharmaceutical compositions comprising one or more compounds of formula I, processes for preparing compounds of formula I, and intermediates useful for preparing compounds of formula I.
PCT/IB2002/001768 2001-06-19 2002-05-13 Quinazolinediones as antibacterial agents WO2002102793A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP02730582A EP1401830A2 (en) 2001-06-19 2002-05-13 Quinazolinediones as antibacterial agents
MXPA03009894A MXPA03009894A (en) 2001-06-19 2002-05-13 Quinazolinediones as antibacterial agents.
CA002446963A CA2446963A1 (en) 2001-06-19 2002-05-13 Quinazolinediones as antibacterial agents
AU2002302894A AU2002302894A1 (en) 2001-06-19 2002-05-13 Quinazolinediones as antibacterial agents
BR0210028-2A BR0210028A (en) 2001-06-19 2002-05-13 Antibacterial agents
JP2003506266A JP2005501021A (en) 2001-06-19 2002-05-13 Antibacterial agent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29924901P 2001-06-19 2001-06-19
US60/299,249 2001-06-19

Publications (2)

Publication Number Publication Date
WO2002102793A2 WO2002102793A2 (en) 2002-12-27
WO2002102793A3 true WO2002102793A3 (en) 2003-04-10

Family

ID=23153973

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2002/001768 WO2002102793A2 (en) 2001-06-19 2002-05-13 Quinazolinediones as antibacterial agents

Country Status (13)

Country Link
EP (1) EP1401830A2 (en)
JP (1) JP2005501021A (en)
AU (1) AU2002302894A1 (en)
BR (1) BR0210028A (en)
CA (1) CA2446963A1 (en)
DO (1) DOP2002000422A (en)
GT (1) GT200200104A (en)
HN (1) HN2002000150A (en)
MX (1) MXPA03009894A (en)
PA (1) PA8548401A1 (en)
PE (1) PE20030272A1 (en)
SV (1) SV2003001089A (en)
WO (1) WO2002102793A2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
US9388185B2 (en) 2012-08-10 2016-07-12 Incyte Holdings Corporation Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
US9533954B2 (en) 2010-12-22 2017-01-03 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
US9533984B2 (en) 2013-04-19 2017-01-03 Incyte Holdings Corporation Bicyclic heterocycles as FGFR inhibitors
US9580423B2 (en) 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US11566028B2 (en) 2019-10-16 2023-01-31 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US11591329B2 (en) 2019-07-09 2023-02-28 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005026154A1 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinolone antibacterial agents
MXPA06005550A (en) * 2003-11-18 2006-08-17 Warner Lambert Co Antibacterial aminoquinazolidinedione derivatives.
US9090568B2 (en) 2011-03-14 2015-07-28 Impact Therapeutics, Inc. Quinazolinediones and their use
TWI527800B (en) 2011-04-01 2016-04-01 南京英派藥業有限公司 1-(arylmethyl)quinazoline-2,4(1h,3h)-diones as parp inhibitors and the use thereof
LT3495367T (en) 2012-06-13 2021-02-25 Incyte Holdings Corporation Substituted tricyclic compounds as fgfr inhibitors
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
WO2016134320A1 (en) 2015-02-20 2016-08-25 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
MA41551A (en) 2015-02-20 2017-12-26 Incyte Corp BICYCLIC HETEROCYCLES USED AS FGFR4 INHIBITORS
CL2015003780A1 (en) 2015-12-30 2016-09-16 Univ Chile Pyrimido-isoquinolin-quinone derivative compounds, their salts, isomers, acceptable pharmaceutical tautomers; farm compositions; preparation procedure; and its use in the treatment of multiresistant bacterial and bacterial diseases.
AR111960A1 (en) 2017-05-26 2019-09-04 Incyte Corp CRYSTALLINE FORMS OF A FGFR INHIBITOR AND PROCESSES FOR ITS PREPARATION
MA52494A (en) 2018-05-04 2021-03-10 Incyte Corp SOLID FORMS OF FGFR INHIBITOR AND THEIR PREPARATION PROCEDURES
EP3788046A1 (en) 2018-05-04 2021-03-10 Incyte Corporation Salts of an fgfr inhibitor
CN111620866A (en) * 2019-02-27 2020-09-04 南京药石科技股份有限公司 Cis-7, 7-difluoro-hexahydro-1H pyrrolo [3,4-c ] pyridine derivative and preparation method thereof
US11628162B2 (en) 2019-03-08 2023-04-18 Incyte Corporation Methods of treating cancer with an FGFR inhibitor
EP4045151A1 (en) 2019-10-14 2022-08-24 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
WO2021113479A1 (en) 2019-12-04 2021-06-10 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
CA3162010A1 (en) 2019-12-04 2021-06-10 Incyte Corporation Derivatives of an fgfr inhibitor
US11738002B2 (en) 2020-04-14 2023-08-29 Sunovion Pharmaceuticals Inc. Methods of treating neurological and psychiatric disorders
TW202313611A (en) 2021-06-09 2023-04-01 美商英塞特公司 Tricyclic heterocycles as fgfr inhibitors

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2120663A1 (en) * 1970-04-27 1971-11-11 Hisamitsu Pharmaceutical Co., Inc., Tosu, Saga (Japan) Quinazolinedione derivatives and process for their preparation
DE2334266A1 (en) * 1972-07-07 1974-01-31 Hisamitsu Pharmaceutical Co PYRIDO SQUARE BRACKET ON 2.3-D SQUARE BRACKET FOR PYRIMIDINE-2,4 (1H, 3H) -DIONE
JPS50142596A (en) * 1974-04-03 1975-11-17
JPS50148368A (en) * 1974-04-25 1975-11-27
DE2446543A1 (en) * 1974-09-28 1976-04-15 Hoechst Ag Monoazomethine pigments - from 3-hydroxy 4-formylnaphthalic acid or derivs.
DE2614148A1 (en) * 1976-04-02 1977-10-20 Henkel & Cie Gmbh OXIDIZING AGENTS, BLEACHING AGENTS AND DETERGENTS WITH A BLEACH ACTIVATOR CONTENT
EP0382687A2 (en) * 1989-02-06 1990-08-16 BOEHRINGER INGELHEIM ITALIA S.p.A. Benzofused-N-containing heterocycle derivatives
WO1994014809A1 (en) * 1992-12-23 1994-07-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Anellated uracil derivates
WO1997024335A1 (en) * 1995-12-28 1997-07-10 Fuji Chemical Industry Co., Ltd. Process for the preparation of 3-dihalobenzyl-2,4-quinazolinedione derivatives
JPH09208543A (en) * 1995-11-29 1997-08-12 Ono Pharmaceut Co Ltd Production of isocyanate derivative and its related compound
EP0789020A1 (en) * 1996-02-01 1997-08-13 Sumitomo Chemical Company, Limited Process for producing dioxoquinazolines
JPH09295977A (en) * 1996-04-30 1997-11-18 Terumo Corp Pyridopyrimidine derivative and medicinal composition containing the same
WO1998018781A2 (en) * 1996-10-28 1998-05-07 Versicor, Inc. Fused 2,4-pyrimidinedione combinatorial libraries, their preparation and the use of fused 2,4-pyrimidinediones derivatives as antimicrobial agents
WO1999021840A1 (en) * 1997-10-28 1999-05-06 Warner-Lambert Company Novel 7-substituted quinazolin-2,4-diones useful as antibacterial agents
WO2001053273A1 (en) * 2000-01-24 2001-07-26 Warner-Lambert Company 3-aminoquinazolin-2,4-dione antibacterial agents
WO2001079206A1 (en) * 2000-04-18 2001-10-25 Sumitomo Pharmaceuticals Company, Limited Tricyclic quinazolinediones
JP2002284699A (en) * 2001-03-28 2002-10-03 Sumitomo Pharmaceut Co Ltd Curative for visual cell degenerative disease

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2120663A1 (en) * 1970-04-27 1971-11-11 Hisamitsu Pharmaceutical Co., Inc., Tosu, Saga (Japan) Quinazolinedione derivatives and process for their preparation
DE2334266A1 (en) * 1972-07-07 1974-01-31 Hisamitsu Pharmaceutical Co PYRIDO SQUARE BRACKET ON 2.3-D SQUARE BRACKET FOR PYRIMIDINE-2,4 (1H, 3H) -DIONE
JPS50142596A (en) * 1974-04-03 1975-11-17
JPS50148368A (en) * 1974-04-25 1975-11-27
DE2446543A1 (en) * 1974-09-28 1976-04-15 Hoechst Ag Monoazomethine pigments - from 3-hydroxy 4-formylnaphthalic acid or derivs.
DE2614148A1 (en) * 1976-04-02 1977-10-20 Henkel & Cie Gmbh OXIDIZING AGENTS, BLEACHING AGENTS AND DETERGENTS WITH A BLEACH ACTIVATOR CONTENT
EP0382687A2 (en) * 1989-02-06 1990-08-16 BOEHRINGER INGELHEIM ITALIA S.p.A. Benzofused-N-containing heterocycle derivatives
WO1994014809A1 (en) * 1992-12-23 1994-07-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Anellated uracil derivates
JPH09208543A (en) * 1995-11-29 1997-08-12 Ono Pharmaceut Co Ltd Production of isocyanate derivative and its related compound
WO1997024335A1 (en) * 1995-12-28 1997-07-10 Fuji Chemical Industry Co., Ltd. Process for the preparation of 3-dihalobenzyl-2,4-quinazolinedione derivatives
EP0789020A1 (en) * 1996-02-01 1997-08-13 Sumitomo Chemical Company, Limited Process for producing dioxoquinazolines
JPH09295977A (en) * 1996-04-30 1997-11-18 Terumo Corp Pyridopyrimidine derivative and medicinal composition containing the same
WO1998018781A2 (en) * 1996-10-28 1998-05-07 Versicor, Inc. Fused 2,4-pyrimidinedione combinatorial libraries, their preparation and the use of fused 2,4-pyrimidinediones derivatives as antimicrobial agents
WO1999021840A1 (en) * 1997-10-28 1999-05-06 Warner-Lambert Company Novel 7-substituted quinazolin-2,4-diones useful as antibacterial agents
WO2001053273A1 (en) * 2000-01-24 2001-07-26 Warner-Lambert Company 3-aminoquinazolin-2,4-dione antibacterial agents
WO2001079206A1 (en) * 2000-04-18 2001-10-25 Sumitomo Pharmaceuticals Company, Limited Tricyclic quinazolinediones
JP2002284699A (en) * 2001-03-28 2002-10-03 Sumitomo Pharmaceut Co Ltd Curative for visual cell degenerative disease

Non-Patent Citations (34)

* Cited by examiner, † Cited by third party
Title
A. N. OSMAN ET AL.: "Synthesis and biological activity of certain derivatives of 2,4-dioxo-1,2,3,4-tetrahydroquinazoline. I", EGYPT. J. CHEM., vol. 25, no. 2, 1982, pages 159 - 164, XP009001225 *
A. N. OSMAN ET AL.: "Synthesis and biological activity of certain derivatives of 2,4-dioxo-1,2,3,4-tetrahydroquinazoline. I", REV. ROUM. CHIM., vol. 27, no. 7, 1982, pages 859 - 864, XP009001179 *
CHATTERJEE, ANAND, J. SCI. IND. RES., vol. 17B, 1958, pages 63 *
CHEMICAL ABSTRACTS, vol. 118, no. 23, 7 June 1993, Columbus, Ohio, US; abstract no. 233993w, H. A. ABDEL-HAMID ET AL.: "Synthesis of some biologically active heterocycles. Reactions of the hydrazide of 2'-thienoylanthranilic acid and its 3,5-dibromo derivative" page 996; XP002210829 *
CHEMICAL ABSTRACTS, vol. 123, no. 25, 18 December 1995, Columbus, Ohio, US; abstract no. 339967j, A. K. SHARMA ET AL.: "Synthesis of some new pyrimidine bases as precursors of potential anticancer nucleosides" page 1164; XP002210830 *
CHEMICAL ABSTRACTS, vol. 127, no. 2, 14 July 1997, Columbus, Ohio, US; abstract no. 17901h, A. K. YADAV ET AL.: "Synthesis of some novel nucleosides of dioxo pyrido[2,3-d]pyrimidines" page 586; XP002210831 *
CHEMICAL ABSTRACTS, vol. 128, no. 4, 26 January 1998, Columbus, Ohio, US; abstract no. 34737x, E. H. EL-TAMANY ET AL.: "Synthesis and antimicrobial activities of some quinazolinone derivatives" page 565; XP002210832 *
CHEMICAL ABSTRACTS, vol. 133, no. 17, 23 October 2000, Columbus, Ohio, US; abstract no. 237941k, S. E. S. BARAKAT: "Synthesis, reactions and antimicrobial activity of 3-aryl-2-pyridiniummethyl-4(3H)-quinazolinone bromides" page 715; XP002210833 *
DATABASE CROSSFIRE BEILSTEIN [online] Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; XP002210834, Database accession no. 8138 *
DATABASE CROSSFIRE BEILSTEIN [online] Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; XP002210835, Database accession no. 157768 *
DATABASE CROSSFIRE BEILSTEIN [online] Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; XP002210836, Database accession no. 383776 *
DATABASE CROSSFIRE BEILSTEIN [online] Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; XP002210837, Database accession no. 1198342 & 1174334 *
DATABASE CROSSFIRE BEILSTEIN [online] Beilstein Institut zur Förderung der Chemischen Wissenschaften, Frankfurt am Main, DE; XP002222384, Database accession no. 329145, 233007 *
EGYPT. J. CHEM., vol. 40, no. 5, 1997, pages 339 - 351 *
EGYPT. J. PHARM. SCI., vol. 39, no. 4-6, 1998, pages 497 - 509 *
F. ISHIKAWA ET AL.: "Cyclic Guanidines. 17. Novel (N-Substituted amino)imidazo[2,1-b]quinazolin-2-ones: Water-Soluble Platelet Aggregation Inhibitors", J. MED. CHEM., vol. 28, no. 10, 1985, pages 1387 - 1393, XP009000843 *
H. G. GARCIA-QUINTANA ET AL.: "Essai de benzotriazepines et quinazolines obtenues par synthèse sur des populations bactériennes", J. VET. MED. B, vol. 34, 1987, pages 341 - 346, XP000985582 *
H. M. S. AHMED: "Antiinflammatory, analgesic and antipyretic activities of certain 1,3 and 1,6 disubstituted and 1,3,6 trisubstituted quinazoline 2,6-dione derivatives", BULL. FAC. PHARM. (CAIRO UNIV.), vol. 19, no. 1, 1980, pages 1 - 9, XP002222379 *
HELLER, J. PRAKT. CHEM. <2>, vol. 111, 1925, pages 19 *
INDIAN J. CHEM. SECT. B: ORG. CHEM. INCL. MED. CHEM., vol. 34B, no. 8, 1995, pages 740 - 742 *
INDIAN J. HETEROCYCL. CHEM., vol. 6, no. 3, 1997, pages 237 - 238 *
J. BOMPART ET AL.: "1H,3H-Quinazoline-2,4-diones: synthesis, physicochemical characterization and study of the stabilization of bovine serum albumin against denaturation", ANNALES PHARMACEUTIQUES FRANCAISES, vol. 46, no. 6, 1989, pages 361 - 370, XP009001198 *
J. BOMPART ET AL.: "Determination of the hydrophobic constants of 1H,3H-quinazoline-2,4-diones", ANNALES PHARMACEUTIQUES FRANCAISES, vol. 46, no. 5, 1988, pages 301 - 308, XP009001200 *
JACINI, GAZZ. CHIM. ITAL., vol. 73, 1943, pages 85 *
K. GROHE, H. HEITZER, JUSTUS LIEBIGS ANN. CHEM., 1974, pages 2066 - 2073 *
M. GÜTSCHOW: "Novel Heterocycles Derived from Substituted Aroylthioureas: Synthesis of 3,1-Benzothiazin-4-ones, Thieno[3,2-d][1,3]thiazin-4-ones and 1,2,4-Thiadiazolo[2,3-a][3,1]benzothiazin-5-ones", J. HETEROCYCL. CHEM., vol. 33, no. 2, 1996, pages 355 - 360, XP002222380 *
M. KHALIFA ET AL.: "Synthesis and Biological Activity of Certain Derivatives of 2,4-Dioxo-1,2,3,4-tetrahydroquinazoline Part 2", EGYPT. J. CHEM., vol. 25, no. 3, 1982, pages 285 - 291, XP000978530 *
M. KHALIFA ET AL.: "Synthesis and Biological Activity of Certain Derivatives of 2,4-Dioxo-1,2,3,4-tetrahydroquinazoline", PHARMAZIE, vol. 37, no. 2, 1982, pages 115 - 117, XP002157063 *
PATENT ABSTRACTS OF JAPAN vol. 1997, no. 12 25 December 1997 (1997-12-25) *
PATENT ABSTRACTS OF JAPAN vol. 1998, no. 03 27 February 1998 (1998-02-27) *
PHOSPHORUS, SULFUR SILICON RELAT. ELEM., vol. 72, no. 1-4, 1992, pages 237 - 247 *
R. BARONNET ET AL.: "Synthèse et pharmacodynamie de dialkylamino-3 1H,3H quinazolinediones-2,4 et de dérivés", EUR. J. MED. CHEM., vol. 18, no. 3, 1983, pages 241 - 247, XP000985490 *
ROBINS, HITCHINGS, J. AMER. CHEM. SOC., vol. 77, 1955, pages 2256 *
Z. BUDESINSKY ET AL.: "Alkoxy-2,4-quinazolinediamines", COLLECT. CZECH. CHEM. COMMUN., vol. 41, no. 11, 1976, pages 3405 - 3414, XP002222381 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9533954B2 (en) 2010-12-22 2017-01-03 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
US9388185B2 (en) 2012-08-10 2016-07-12 Incyte Holdings Corporation Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
US9533984B2 (en) 2013-04-19 2017-01-03 Incyte Holdings Corporation Bicyclic heterocycles as FGFR inhibitors
US9580423B2 (en) 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US11591329B2 (en) 2019-07-09 2023-02-28 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US11566028B2 (en) 2019-10-16 2023-01-31 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors

Also Published As

Publication number Publication date
DOP2002000422A (en) 2002-12-30
EP1401830A2 (en) 2004-03-31
PE20030272A1 (en) 2003-03-21
AU2002302894A1 (en) 2003-01-02
BR0210028A (en) 2004-06-22
WO2002102793A2 (en) 2002-12-27
CA2446963A1 (en) 2002-12-27
GT200200104A (en) 2003-02-11
JP2005501021A (en) 2005-01-13
HN2002000150A (en) 2002-09-13
PA8548401A1 (en) 2003-05-14
SV2003001089A (en) 2003-03-18
MXPA03009894A (en) 2004-02-17

Similar Documents

Publication Publication Date Title
WO2002102793A3 (en) Quinazolinediones as antibacterial agents
WO2004074244A3 (en) Pyrimidine compounds
WO2002064594A3 (en) 6-substituted pyrido-pyrimidines
WO2002048147A3 (en) Pyrazolopyridines
WO2003095455A3 (en) Substituted pyrazolopyrimidines
UA91007C2 (en) Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
HUP0402338A3 (en) Spiro-hydantoin compounds, their use as anti-inflammatory agents, pharmaceutical compositions containing them and intermediates for preparing them
WO2003037860A3 (en) Purine analogs having hsp90-inhibiting activity
AU2002305143A1 (en) Pyrazolo&#39;1,5-a!pyridine derivatives
AP2002002616A0 (en) Antidibetic agents
WO2002048148A3 (en) Pyrazolopyridine derivatives
WO2003017924A3 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
WO2003053971A8 (en) Pyridoquinoxaline antivirals
WO2004014906A3 (en) Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents
WO2003015780A3 (en) Isoxazolopyridinones and use thereof in the treatment of parkinson&#39;s disease
WO2004047724A3 (en) Aryl and heteroaryl compounds as antibacterial and antifungal agents
WO2004087652A3 (en) Imidazotriazine compounds
WO2003051838A3 (en) Protein kinase inhibitors
WO2002072581A3 (en) Pyrazolopyriadine derivatives
WO2004089943A8 (en) Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
WO2003045940A3 (en) Benzazepine derivatives and their use as 5-ht ligands
WO2005007083A3 (en) Chemical compounds
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
WO2003017762A3 (en) Fungicidal active-ingredient combinations

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: PA/a/2003/009894

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2446963

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002730582

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2003506266

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2002730582

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2002730582

Country of ref document: EP